Valiant Laboratories Limited (NSE:VALIANTLAB)
70.46
+1.07 (1.54%)
Jan 5, 2026, 3:30 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 3.77 billion as of January 5, 2026. Its market cap has decreased by -25.60% in one year.
Market Cap
3.77B
Enterprise Value
3.68B
Revenue
1.86B
Ranking
n/a
PE Ratio
67.28
Stock Price
70.46
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 3.77B, a decrease of -49.05%. That is a compound annual growth rate of -25.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 3.77B | -0.87% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.70T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 922.62B |
| Mankind Pharma | 909.29B |
| Aurobindo Pharma | 705.91B |
| Fortis Healthcare | 690.60B |